|
Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer Clinical research trials and Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer. Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer  Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
For Condition: childhood thorax/respiratory cancer,Quality of Life,stage 2 non-small cell lung cancer,stage 1 non-small cell lung cancer,limited stage small cell lung cancer
Status: No longer recruiting
Sponsor(s): Royal Marsden NHS Trust ,
Synopsis: RATIONALE: Diagnostic procedures and treatment-planning systems may affect outcome in patients suspected of having lung cancer. PURPOSE: Randomized diagnostic trial to compare the effectiveness of two types of diagnostic and treatment-planning systems in patients who are suspected of having lung cancer.
Details: OBJECTIVES: I. Compare the survival rate of patients with suspected lung cancer when diagnosed and managed using the conventional locally based approach versus a new centralized system using a 2 stop diagnosis. II. Compare the resection rate in both diagnostic arms. III. Assess the quality of service given in both diagnostic arms. PROTOCOL OUTLINE: This is a randomized study. Patients present to a general practitioner where they are referred to the local chest clinic. Patients are seen by the chest physician and, if deemed eligible, are randomized between 2 diagnostic arms. Arm I (Conventional Locally Based Diagnosis): Patients undergo bronchoscopy and CT scan as appropriate, and then are discussed or referred by individual chest physicians, as is the current practice. The optimal period for diagnosis and discussion of management plans is 6 weeks. Arm II (Centralized 2 Stop Diagnosis): Patients undergo CT scan the following Monday morning. The consultant radiologist advises the most appropriate diagnostic test (e.g., bronchoscopy or percutaneous needle biopsy) to be done that same Monday. A tissue diagnosis is available Thursday morning for the multidisciplinary meeting attended by the chest physician, medical and clinical oncologists, and a surgeon, and the patient treatment plan is decided. Quality of life is assessed at baseline and at 6 weeks. Patients are followed for 2 years. PROJECTED ACCRUAL: A total of 252-315 patients will be accrued for this study within 2 years.
Eligibility:
Study Type: Interventional, Diagnostic
Minimum Age/Maximum Age: /
Genders:
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - Possible diagnosis of lung cancer - Fit enough for bronchoscopy and CT scan --Prior/Concurrent Therapy-- - Not specified --Patient Characteristics-- - Age: Not specified - Performance status: Not specified - Life expectancy: Not specified - Hematopoietic: Not specified - Hepatic: Not specified - Renal: Not specified
Total Enrollment:
Location and Contact Information:
Overall Study Official:
MaryO'Brien, Study Chair, Royal Marsden NHS Trust
Royal Marsden Hospital
Sutton, England, SM2 5PT
United Kingdom
Additional Information:
Study ID Numbers: CDR0000067676; RMNHS-PATHWAY,EU-99039
Study Start Date: October 1998
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005071
Other Quality Of Life Studies:
1. Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer
2. Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
3. Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
4. Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer
5. Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
Related Studies:
Other Quality of Life Clinical Trials
Other England Clinical Trials
Other Sutton Clinical Trials
Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
|
|
|
|
|
|
|
|
